Related Experiment Videos
Structured triglyceride emulsions in parenteral nutrition
C Chambrier1, M Lauverjat, P Bouletreau
1Unité de Nutrition Clinique Intensive, Hôpital Edouard Herriot, 5 place d'Arsonval, 69003 Lyon, France. cecile.chambrier@chu-lyon.fr
Summary
Structured-lipid emulsions show potential in improving nitrogen balance and lipid metabolism compared to standard IV fat emulsions. Further research is needed to confirm their clinical benefits and optimize their use.
Area of Science:
- Nutritional Science
- Biochemistry
- Clinical Nutrition
Background:
- Intravenous fat emulsions (IVFE) have evolved over 30 years.
- A novel structured-lipid emulsion, utilizing older technology, is now available.
- This emulsion is synthesized by combining medium-chain and long-chain triglycerides.
Purpose of the Study:
- To evaluate the efficacy and safety of a newly available structured-lipid emulsion.
- To compare its effects on nitrogen balance, lipid metabolism, and liver function against standard IVFE formulations.
- To assess its impact on the reticuloendothelial system.
Main Methods:
- Animal studies demonstrated improved nitrogen balance with structured-lipid emulsions.
- Eight human clinical studies were conducted to assess clinical outcomes.
- Comparisons were made against long-chain triglycerides (LCT) and LCT-medium-chain triglycerides (LCT-MCT) mixtures.
Main Results:
- Human clinical study results were less promising than animal data.
- Structured-lipid emulsions showed improved nitrogen balance and lipid metabolism over LCT and LCT-MCT.
- These emulsions resulted in less elevation of serum liver function values and no adverse effects on the reticuloendothelial system compared to standard IVFEs.
Conclusions:
- Structured-lipid emulsions offer potential advantages over standard IVFE, including better nitrogen balance and lipid metabolism.
- While promising, further clinical studies are essential to establish definitive recommendations for their use.
- Future developments aim for chemically defined structured triglycerides for targeted clinical applications.